Gibtulio Met 12.5mg/1000mg Tablet


Product Info

Prescription required Yes
Marketer Lupin Ltd
Active Ingredient Empagliflozin (12.5mg) + Metformin (1000mg)
Storage Store below 30°C
Habit FormingNo
Therapeutic ClassANTI DIABETIC
User Rating4.3
User Reviews327

FAQ

Question
What if you forget to take Gibtulio Met Tablet?
If you miss a dose of Gibtulio Met 12.5mg/1000mg, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Answer

Gibtulio Met 12.5mg/1000mg Tablet Reviews

Gibtulio Met 12.5mg/1000mg is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar level.

Gibtulio Met 12.5mg/1000mg should be taken with food at any time of day but you should try to take it at the same time every day. The dose will be decided by your doctor. Don’t stop taking it without asking your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness. This medicine is only part of a treatment program that should include a healthy diet, regular exercise, and weight reduction as advised by your doctor.

The most common side effects of this medicine include taste changes, nausea, vomiting, diarrhea, joint pain, urinary tract infection, and yeast infections. Drinking plenty of fluids while using it will help prevent dehydration. Some people may develop fungal infections in the genital area. Maintaining good hygiene can help prevent this.

Before taking this medicine, inform your doctor if you have any kidney or liver problems or a urinary tract infection or if you are on water pills (diuretics). Pregnant or breastfeeding women should also consult their doctor before taking it. Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects. Monitor your blood sugar levels regularly while taking this medicine.

How Gibtulio Met 12.5mg/1000mg Tablet Works

Gibtulio Met 12.5mg/1000mg is a combination of two antidiabetic medicines: Empagliflozin and Metformin. Empagliflozin works by removing excess glucose from your body through urine. Metformin works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Together, they lower blood glucose more effectively.

How to Use Gibtulio Met 12.5mg/1000mg Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Gibtulio Met 12.5mg/1000mg may be taken with or without food, but it is better to take it at a fixed time.

Benefits of Gibtulio Met 12.5mg/1000mg Tablet

  • In Treatment of Type 2 diabetes mellitus: Gibtulio Met 12.5mg/1000mg is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. This medicine will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.

Uses of Gibtulio Met 12.5mg/1000mg Tablet

  • Treatment of Type 2 diabetes mellitus

Gibtulio Met 12.5mg/1000mg Tablet Side Effects

Item form

Safety Tips

Alcohol  CAUTION
Caution is advised when consuming alcohol with Gibtulio Met 12.5mg/1000mg. Please consult your doctor.
Liver  CAUTION
Gibtulio Met 12.5mg/1000mg should be used with caution in patients with liver disease. Dose adjustment of Gibtulio Met 12.5mg/1000mg may be needed. Please consult your doctor.
Pregnancy  CONSULT YOUR DOCTOR
Gibtulio Met 12.5mg/1000mg may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Driving  UNSAFE
Gibtulio Met 12.5mg/1000mg may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney  UNSAFE
Gibtulio Met 12.5mg/1000mg is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Breast feeding  CONSULT YOUR DOCTOR
Gibtulio Met 12.5mg/1000mg is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Quick Tips

  • It also reduces the risk of heart attack, heart failure or other cardiovascular events.
  • You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines (if prescribed) along with Gibtulio Met 12.5mg/1000mg.
  • It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Monitor your blood sugar level regularly.
  • Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor, and anxious feeling.
  • Practice good genital hygiene to prevent yeast or urinary tract infections
  • You have been prescribed this combination medicine as it can control blood sugar better than metformin alone.
  • It may cause your body to lose too much fluid (dehydration) or you to urinate more often. Drink plenty of water and stay hydrated. 
  • Take it with food to lower your chance of having an upset stomach.

References

  1. Empagliflozin and metformin hydrochloride extended-release (Synjardy XR) [FDA Prescribing Information]. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2016.
  2. Empagliflozin and Metformin hydrochloride [Patient Information Sheet]. Ahmedabad, Gujarat: TORRENT PHARMACEUTICAL LIMITED; 2022.
  3. Empagliflozin and metformin hydrochloride tablets (Synjardy) [Product Monograph]. Burlington, ON: Boehringer Ingelheim (Canada) Ltd.; 2020.

Other Medical Preparations